Vitamin D insufficiency or deficiency Vitamin D, insufficiency, deficiency, supplementation
Conditions
Interventions
Vitamib D2 ( Ergocalciferol) 400 IU/day oral route for 4 weeks,Vitamib D2 ( Ergocalciferol) 800 IU/day oral route for 4 weeks
Sham Comparator Dietary Supplement,Experimental Dietary Supplement
Vitamib D2 ( Ergocalciferol) 400 IU,Vitamib D2 ( Ergocalciferol) 800 IU
Sponsors
Children hospital foundation
Eligibility
Sex/Gender
All
Age
1 Hours to No maximum
Inclusion criteria
Inclusion criteria: 1.preterm infant below 34 weeks of gestational age and birthweight below 1800 grams 2.recieved full fortified human milk (150 ml/kg/day or more and 24kcal/oz)
Exclusion criteria
Exclusion criteria: exclude sample who has 1.major congenital anomaly 2.chromosomal abnormality 3.gastrointestinal abnormalities (obstruction or malabsorption) 4.major surgery 5. bone fracture 6.premature formular usued
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| comparison the efficacy of oral vitamin D supplemented doses 400 iu/day and 800 iu/day in preterm infants at 4 weeks after beginning of the intervention Vitamin D level in serum | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of vitamin D deficiency in preterm infants at birth Within 24 hours after birth Vitamin D level in serum,Incidence of vitamin d deficiency consequences in preterm infants at 4 weeks after beginning of the intervention Vitamin D level in serum, Incidence of vitamin D toxicity incontrol and intervention groups at 4 weeks after beginning of the intervention Vitamin D level in serum | — |
Countries
Thailand
Contacts
Public ContactJitthip Yeepae
Queen Sirikit National Institute of Child Health (QSNICH)
Outcome results
None listed